U-Tract® Caps Progressive Labs

Description

Description

U-Tract® Caps is a unique product designed to support urinary tract health.  The active ingredient, D-mannose, is a simple sugar that is found in many fruits such as cranberries, pineapples and other plant sources.  Small amounts of U-Tract® Caps are metabolized by the body, with the remainder being excreted via the urine.‡

As U-Tract® Caps is flushed from the body it maintains a healthy environment in the urinary tract, supporting the urinary tract mucosal surface and helping to bind and flush bacteria from the system.‡

U-Tract® Caps is produced from natural sources – birch and beech wood hydrolysates. Though D-mannose is a simple sugar, it is not converted to glycogen like many sugars and is not stored in the liver.‡

 

 

Warning:  If you are pregnant or lactating woman, have any health conditions, or are taking any medication, make sure to consult your healthcare provider prior to use.

‡ These statements have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease.

Ingredients

Dosage

Four capsules three or four times daily.
Then take four capsules twice daily for two or three more days.
May be taken with or between meals.

Count

90 Capsules

Science

Wagenlehner F, Lorenz H, Ewald O, Gerke P. Why d-Mannose May Be as Efficient as Antibiotics in the Treatment of Acute Uncomplicated Lower Urinary Tract Infections-Preliminary Considerations and Conclusions from a Non-Interventional Study. Antibiotics (Basel). 2022 Feb 25;11(3):314. doi: 10.3390/antibiotics11030314. PMID: 35326777; PMCID: PMC8944421.

Ala-Jaakkola, R., Laitila, A., Ouwehand, A.C. et al. Role of D-mannose in urinary tract infections – a narrative review. Nutr J 21, 18 (2022). https://doi.org/10.1186/s12937-022-00769-x

Altarac, S. and Papeš, D. (2014), Comment. BJU Int, 113: 9-10. https://doi.org/10.1111/bju.12492

Porru D, Parmigiani A, Tinelli C, et al. Oral D-mannose in recurrent urinary tract infections in women: a pilot study. Journal of Clinical Urology. 2014;7(3):208-213. doi:10.1177/2051415813518332

D-mannose: a promising support for acute urinary tract infections in women. A pilot study. L. DOMENICI, M. MONTI, C. BRACCHI, M. GIORGINI, V. COLAGIOVANNI, L. MUZII, P. BENEDETTI PANICI, Department of Gynecological Obstetrics and Urologic Sciences, University Sapienza of Rome, Rome, Italy, 2016; 20: 2920-2925

D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis, Stacy M. Lenger, MD, Megan S. Bradley, MD, Debbie A. Thomas, MLS, Marnie H. Bertolet, PhD, Jerry L. Lowder, MD, MSc, Siobhan Sutcliffe, PhD, SCM, MHS, Published:June 01, 2020DOI:https://doi.org/10.1016/j.ajog.2020.05.048

Kranjčec, B., Papeš, D. & Altarac, S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol 32, 79–84 (2014). https://doi.org/10.1007/s00345-013-1091-6

Parazzini F, Ricci E, Fedele F, Chiaffarino F, Esposito G and Cipriani S: Systematic review of the effect of D‑mannose with or without other drugs in the treatment of symptoms of urinary tract infections/cystitis (Review). Biomed Rep 17: 69, 2022

Hickling DR, Nitti VW. Management of recurrent urinary tract infections in healthy adult women. Rev Urol. 2013;15(2):41-8. PMID: 24082842; PMCID: PMC3784967.

Features :

• Hygienic Product : Not Specified
• Allergy : Not Specified

Specifications

• UPC:Not Specified
• GTIN/ITF Barcode : Not Specified
• Units of Measure : Not Specified
• Overall Product Length : Not Specified in
• Overall Product Width : Not Specified in
• Overall Product Height : Not Specified in
• Weight Capacity : Not Specified lbs
• Actual Product Weight : 0.25
• Product Assembly : Not Specified
• Product Installation : Not Specified
• Country of Origin : Not Specified
• Case QTY : Not Specified/case
• Case Weight : Not Specified
• Ships Via Freight : No
• Proposition 65 Warning : Not Specified